Gene editing technology for treatment-resistant cancer could be a 'scientific layup' to treat other diseases

Description

For the first time, a new gene editing technology called base editing was used to modify immune cells and successfully treat a teen with treatment-resistant leukemia. A month afterward, 13-year-old Alyssa was in remission, and she continues to do well several months later.

Vector engineering, strategies and targets in cancer gene therapy

Gene editing technology for treatment-resistant cancer could be a 'scientific layup' to treat other diseases

HOPA Bulletin

100,000 newborn babies will have their genomes sequenced in the UK. It could have big implications for child medicine

Pfizer tags early research programs for 'externalization' as it narrows focus in rare disease, cancer : r/biotechnologynews

Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer, Molecular Cancer

Gene editing technology for treatment-resistant cancer could be a 'scientific layup' to treat other diseases, Health

Alexa Miller on LinkedIn: CRISPR-Cas9: From Bacterial Adaptive Immune Response To Editing and…

Cancers, Free Full-Text

$ 24.50USD
Score 5(314)
In stock
Continue to book